Strängnäs, Sweden

Seth-Olov Thorberg


Average Co-Inventor Count = 3.7

ph-index = 6

Forward Citations = 111(Granted Patents)


Location History:

  • Jarna, SE (1980 - 1999)
  • Strangnas, SE (2000)
  • Str{umlaut over (a)}ngn{umlaut over (a)}s, SE (2001)
  • Strängnäs, SE (2001 - 2008)

Company Filing History:


Years Active: 1980-2008

Loading Chart...
32 patents (USPTO):Explore Patents

Title: Seth-Olov Thorberg: A Pioneer in Pharmaceutical Innovations

Introduction

Seth-Olov Thorberg, hailing from Strängnäs, Sweden, is a notable inventor in the pharmaceutical field. With a significant portfolio of 32 patents, he has made substantial contributions to the development of new chemical entities that hold promise for various therapeutic applications.

Latest Patents

Among his latest patents, two noteworthy inventions stand out: the "Substituted Indan Derivatives" and the "Substituted Chroman Derivatives." The former pertains to intermediates useful in the creation of piperazinyl-substituted indan derivatives, which could serve as vital components in medicinal chemistry. Meanwhile, his second patent focuses on new piperidyl- or piperazinyl-substituted dihydro-2H-1-benzopyran derivatives, expanding the scope of potential pharmaceutical agents.

Career Highlights

Seth-Olov has had a distinguished career, particularly with his tenure at leading pharmaceutical companies like AstraZeneca AB and Astra Aktiebolag. His work in these esteemed organizations has solidified his reputation as a forward thinker in drug development, allowing him to participate in groundbreaking research that enhances patient care.

Collaborations

Throughout his career, Seth-Olov has collaborated with esteemed colleagues such as Svante Bertil Ross and Stefan Berg. These partnerships have fostered an environment of innovation, combining diverse expertise to enhance the quality and efficacy of new inventions.

Conclusion

Seth-Olov Thorberg's contributions to the field of pharmaceutical innovations are marked by a remarkable array of patents and a collaborative spirit. His latest inventions spotlight his ongoing commitment to advancing medical science, ultimately benefiting society through improved therapeutics. With a solid foundation in his past experiences and collaborations, the future of his research endeavors holds great promise for further advancements in the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…